<DOC>
	<DOC>NCT00434590</DOC>
	<brief_summary>The study will evaluate kidney graft function in maintenance renal transplant patients.</brief_summary>
	<brief_title>Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Inclusion criteria: Male or female recipients of single or double renal transplant performed since at least one year and no more that 5 years Age &gt; 18 yrs Adequate and stable renal function Informed consent. Exclusion criteria: Kidney transplant combined with other organs; Significant proteinuria Severe ongoing infections; Present or historical malignant neoplasia, of any type, with the exception of excised non metastatic nonmelanoma skin cancer and previous malignant neoplasia cured since at least 5 years; Relapse of the endstage renal disease on the transplanted kidney; Leucopenia, thrombocytopenia or severe anemia; Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Mycophenolic Acid</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Cyclosporine</keyword>
</DOC>